The Resource Drug safety : further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse

Drug safety : further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse

Label
Drug safety : further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives
Title
Drug safety
Title remainder
further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives
Statement of responsibility
statement of Marcia Crosse
Title variation
  • Drug safety
  • Further actions needed to improve FDA's postmarket decision-making process
Title variation remainder
further actions needed to improve Food and Drug Administration's postmarket decision making process
Creator
Contributor
Subject
Genre
Language
eng
Member of
Cataloging source
GPO
http://library.link/vocab/creatorName
Crosse, Marcia
Government publication
federal national government publication
Index
no index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
  • United States
  • United States
Series statement
Testimony
Series volume
GAO-07-856 T
http://library.link/vocab/subjectName
  • United States
  • Drugs
  • Drugs
Label
Drug safety : further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
Instantiates
Publication
Note
  • Title from title screen (viewed on July 3, 2007)
  • "For release ... May 9, 2007."
  • Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
mixed
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Dimensions
unknown
Extent
13 pages
Form of item
electronic
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
digital, PDF file.
Specific material designation
remote
System details
Mode of access: Internet from GPO Access web site. Address as of 7/3/07: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:d07856t.pdf; current access available via PURL
Label
Drug safety : further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
Publication
Note
  • Title from title screen (viewed on July 3, 2007)
  • "For release ... May 9, 2007."
  • Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
mixed
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Dimensions
unknown
Extent
13 pages
Form of item
electronic
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
digital, PDF file.
Specific material designation
remote
System details
Mode of access: Internet from GPO Access web site. Address as of 7/3/07: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:d07856t.pdf; current access available via PURL

Library Locations

    • Biddle Law LibraryBorrow it
      3400 Chestnut Street, Philadelphia, Pennsylvania, 19104, US
      39.954941 -75.193362
Processing Feedback ...